Differences in prevalence of hypertension subtypes according to the 2018 Korean Society of Hypertension and 2017 American College of Cardiology/American Heart Association guidelines: The Korean National Health and Nutrition Examination Survey, 2007–2017 (KNHANES IV-VII)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnostic criteria embodied by the 2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) and 2018 Korean Society of Hypertension (2018 KSH) guidelines. Methods: We used the 2007–2017 Korea National Health and Nutrition Examination Survey (KNHANES) data to calculate guideline-specific hypertension prevalence among untreated, adult participants. By the 2017 ACC/AHA guideline, a mean SBP ≥130 mmHg, DBP ≥80 mmHg, or currently using antihypertensive medications were considered to have hypertension. Isolated diastolic hypertension (IDH) was defined as DBP ≥80 mmHg and SBP < 130 mmHg, isolated systolic hypertension (ISH) as SBP ≥130 mmHg and DBP <80 mmHg, and systolic diastolic hypertension (SDH) as SBP ≥130 mmHg and DBP ≥80 mmHg. In a similar manner, by the 2018 KSH guideline, all hypertension and its subtype prevalence were calculated using the 140/90 mmHg cutoff. The two versions of all hypertension and its corresponding subtype prevalence were calculated among all study participants and separately by sex and age then compared via analysis of variance. Results: The prevalence of all hypertension increased from 25.9% (95% confidence interval (CI) 25.4–26.5) defined by the 2018 KSH guideline to 46.3% (95% CI 45.6–46.9) classified by the 2017 ACC/AHA guideline. Such increase was primarily manifested through substantial increase in IDH prevalence, from 5.2% (95% CI 4.9–5.4) defined by the 2018 KSH guideline to 17.9% (95% CI 17.4–18.3) defined by the 2017 ACC/AHA guideline, and was most notably observed in young age groups, 30-49 years. ISH prevalence showed minimal differences. SDH prevalence moderately increased from 3.5% (95% CI 3.3–3.7) defined by the 2018 KSH guideline to 11.1% (95% CI 10.7–11.4) defined by the 2017 ACC/AHA guideline, achieved primarily among participants aged 50 years or above. Conclusions: Changes in each subtype prevalence made differential contribution to additionally classified hypertension cases by the 2017 ACC/AHA guideline. Future studies should investigate the diastolic-associated cardiovascular risks and benefits of its long-term primary prevention in the young population.
Abstract
Background: The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnostic criteria embodied by the 2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) and 2018 Korean Society of Hypertension (2018 KSH) guidelines. Methods: We used the 2007–2017 Korea National Health and Nutrition Examination Survey (KNHANES) data to calculate guideline-specific hypertension prevalence among untreated, adult participants. By the 2017 ACC/AHA guideline, a mean SBP ≥130 mmHg, DBP ≥80 mmHg, or currently using antihypertensive medications were considered to have hypertension. Isolated diastolic hypertension (IDH) was defined as DBP ≥80 mmHg and SBP < 130 mmHg, isolated systolic hypertension (ISH) as SBP ≥130 mmHg and DBP <80 mmHg, and systolic diastolic hypertension (SDH) as SBP ≥130 mmHg and DBP ≥80 mmHg. In a similar manner, by the 2018 KSH guideline, all hypertension and its subtype prevalence were calculated using the 140/90 mmHg cutoff. The two versions of all hypertension and its corresponding subtype prevalence were calculated among all study participants and separately by sex and age then compared via analysis of variance. Results: The prevalence of all hypertension increased from 25.9% (95% confidence interval (CI) 25.4–26.5) defined by the 2018 KSH guideline to 46.3% (95% CI 45.6–46.9) classified by the 2017 ACC/AHA guideline. Such increase was primarily manifested through substantial increase in IDH prevalence, from 5.2% (95% CI 4.9–5.4) defined by the 2018 KSH guideline to 17.9% (95% CI 17.4–18.3) defined by the 2017 ACC/AHA guideline, and was most notably observed in young age groups, 30-49 years. ISH prevalence showed minimal differences. SDH prevalence moderately increased from 3.5% (95% CI 3.3–3.7) defined by the 2018 KSH guideline to 11.1% (95% CI 10.7–11.4) defined by the 2017 ACC/AHA guideline, achieved primarily among participants aged 50 years or above. Conclusions: Changes in each subtype prevalence made differential contribution to additionally classified hypertension cases by the 2017 ACC/AHA guideline. Future studies should investigate the diastolic-associated cardiovascular risks and benefits of its long-term primary prevention in the young population.
참고문헌 (45)
- GBD 2017 Risk Factor Collaborators, "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks of clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1923~1994 (2018)
- Global status report on noncommunicable diseases 2010, "World Health Organization", World Health Organization, ~ (2011)
- Go AS, "and the American Heart Association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association", Circulation, 127, pp.e6~e245 (2013)
- Shin J, "2013 Korean Society of Hypertension guidelines for the management of hypertension : part Iepidemiology and diagnosis of hypertension", Clin Hypertens, 21, pp.1~ (2015)
- Wilkins JT, "Lifetime risk and years lived free of total cardiovascular disease", JAMA, 308, pp.1795~1801 (2012)
- Chow CK, "Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries", JAMA, 310, pp.959~968 (2013)
- Kim H, "Korea hypertension fact sheet", Clin Hypertens, 24, pp.13~ (2018)
- Hokyou Lee, "Temporal and Geospatial Trends of Hypertension Management in Korea: a Nationwide Study 2002–2016", Korean Circulation Journal, 49(6), pp.514~527 (2019), 대한심장학회[DOI]
- Lewington S, "Prospective studies C. age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies", Lancet, 350, pp.1903~1913 (2002)
- Rapsomaniki E, "Blood pressure and incidence of twelve cardiovascular diseases:lifetime risks, healthy life-years lost, and age-specific associations in 1.25million people", Lancet, 383, pp.1899~1911 (2014)
- Bohm M, "Achieved blood pressure and cardiovascular outcomes in high-risk patients : results from ONTARGET and TRANSCEND trials", Lancet, 389, pp.2226~2237 (2017)
- Lim SS, "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010 : a systematic analysis for the global burden of Disease study 2010", Lancet, 380, pp.2224~2260 (2012)
- Williams B, "Systolic pressure is all that matters", Lancet, 371, pp.2219~2221 (2008)
- Lindenstrom E, "Influence of systolic and diastolic blood pressure on stroke risk : a prospective observational study", Am J Epidemiol, 142(12), pp.1279~1290 (1995)
- Benetos A, "Prognostic value of systolic and diastolic blood pressure in treated hypertensive men", Arch Intern Med, 162, pp.577~581 (2002)
- Choi YJ, "Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events : a nationwide population-based study from Korea", Eur Heart J, 40, pp.724~731 (2018)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Chobanian AV, "Seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure", Hypertension, 42, pp.1206~1252 (2003)
- Hae-Young Lee, "2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension", Clinical Hypertension, 25(4), pp.51~74 (2019), 대한고혈압학회[DOI]
- Kweon S, "Data resource profile : The Korea national health and nutrition examination survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
- Kim Y, "The Korea National Health and Nutrition Examination Survey(KNHANES) : current status and challenges", Epidemiol Health, 36, pp.e2014002~ (2014)
- 오지연, "한국어판 단문형 국제신처활동설문(IPAQ)의 신뢰도와 타당도", Korean Journal of Family Medicine, 28(7), pp.532~541 (2007), 대한가정의학회
- 김미경, "2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea", Diabetes and Metabolism Journal, 43(4), pp.398~406 (2019), 대한당뇨병학회[DOI]
- 이은정, "2018 Guidelines for the management of dyslipidemia", The Korean Journal of Internal Medicine, 34(4), pp.723~771 (2019), 대한내과학회[DOI]
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150(9), pp.604~612 (2009)
- Disease K, "Improving Global Outcomes (KDIGO) Hepatitis C Work Group:KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease", Kidney Int Suppl, 8(3), pp.91~165 (2018)
- Goff DC Jr, "2013 ACC", AHA guideline on the assessment of cardiovascular risk : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
- Jung KJ, "The ACC", AHA 2013pooled cohort equations compared to a Korean risk prediction model for atherosclerotic cardiovascular disease, 2015, pp.242(1), 367~375
- Hense HW, "Why is blood pressure control unsatisfactory—or is it?", Nephrol Dial Transplant, 17, pp.1547~1550 (2002)
- 김나래, "Prevalence and Trends of Hypertension Subtypes among Korean Adults: the Korea National Health and Nutrition Examination Survey, 1998-2012.", Korean Circulation Journal, 45(6), pp.492~499 (2015), 대한심장학회[DOI]
- So Mi Jemma Cho, "Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013–2015 (KNHANES VI)", Korean Circulation Journal, 49(11), pp.1035~1048 (2019), 대한심장학회[DOI]
- Qi SF, "Prevalence of hypertension subtypes in 2011 and the trends from 1991-2011 among Chinese adults", J Epidemiol Community Health, 70(5), pp.444~451 (2016)
- Muntner P, "Potential US population impact of the 2017 ACC", AHA high blood pressure guideline, 2018, pp.137, 109~118
- The WJ, "A randomized trial of intensive versus standard blood-pressure control", Vnitr Lek, 62(1), pp.44~47 (2016)
- Lonn EM, "Bloodpressure lowering in intermediate-risk persons without cardiovascular disease", N Engl J Med, 374, pp.2009~2020 (2016)
- The ACCORD Study Group, "Effects of intensive blood-pressure control in type 2 diabetes mellitus", N Engl J Med, 362, pp.1575~1585 (2010)
- Ettehad D, "Blood pressure lowering for prevention of cardiovascular disease and death : a systematic review and meta-analysis", Lancet, 387, pp.957~967 (2016)
- Brunstrom M, "Perspective from Sweden on the global impact of the 2017 American College of Cardology", American Heart Association hypertension guidelines, 2018, pp.137, 886~888
- Strandberg TE, "Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years", J Hypertens, 20, pp.399~404 (2002)
- Benavente OR, "The secondary prevention of small subcortical strokes(SPS3)study", Int J Stroke, 6, pp.164~175 (2011)
- Allen NB, "Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age", JAMA, 311(5), pp.490~497 (2014)
- Zhang Y, "Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events", J Am Coll Cardiol, 74(3), pp.330~341 (2019)
- Williams B, "2018ESC", ESH guidelines for the management of arterial hypertension, 2018, pp.369(33), 3021~3104
- Lee H, "Combined effect of income and medication adherence on mortality in newly treated hypertension : nationwide study of 16 million person-years", J Am Heart Assoc, 8, pp.e013148~ (2019)
- Mancia G, "Diagnosis and management of patients with white-coat and masked hypertension", Nat Rev Cardiol, 8(12), pp.686~693 (2011)